ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Medplus reported strong revenue growth but faced significant margin pressure from a lower private label mix and rising employee costs due to regulatory changes.
MedPlus reported Q1 FY27 revenue of ₹18,796M (+21.8% YoY) but saw Operating EBITDA decline 10.6% YoY to ₹651M. Strategy focuses on store network expansion, particularly franchisees.
MedPlus reported Q4 FY26 consolidated revenue of INR 18,644 million with a 5.8% EBITDA margin. Strategy shifts toward a franchisee model for faster, capital-efficient expansion.
Medplus delivered strong revenue growth while pivoting toward a franchise-led expansion model to optimize capital allocation. Management maintains a confident tone despite store closures and fluctuating private label contributions.
MedPlus FY26 revenue reached ₹68,925m, up 12.3% YoY. Strategy focuses on cluster-based expansion with 5,330 stores and increasing private label share.